Brief: Lifemd Inc And Ascend Therapeutics Launch Integrated D2C Telehealth Model For Hormone Therapy
21/09/2023 11:04
Sept 21 (Reuters) - LifeMD Inc LFMD.O :
* LIFEMD INC - LIFEMD AND ASCEND THERAPEUTICS LAUNCH
INTEGRATED
DIRECT-TO-CONSUMER TELEHEALTH MODEL FOR HORMONE THERAPY
Source text for Eikon: ID:nGNXPkwQz
Further company coverage: LFMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LifeMD
See all newsLifeMD Inc reports results for the quarter ended June 30 - Earnings Summary
LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs
Brief: LifeMD Inc Q2 Revenue USD 47.3 Million Vs. IBES Estimate USD 49.2 Million
LifeMD Inc expected to post a loss of 15 cents a share - Earnings Preview
LifeMD Q1 revenue beats estimates on record telehealth subscriber additons